0 NYSE Companies - March 27, 2025Acuity Inc. Declares Quarterly DividendAtlanta, March 27, 2025 (GLOBE NEWSWIRE) — Acuity Inc. (NYSE: AYI) will pay a quarterly dividend of 17 cents per share. […]Read More
0 NASDAQ Companies - March 27, 2025INmune Bio Inc. Announces Year End 2024 Results and Provides a Business UpdateBOCA RATON, Fla., March 27, 2025 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology […]Read More
0 NASDAQ Companies - March 27, 2025Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025CHASKA, Minn., March 27, 2025 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and […]Read More
0 NASDAQ Companies - March 27, 2025Wintrust Names New Leader for Brand, Engagement, and ImpactROSEMONT, Ill., March 27, 2025 (GLOBE NEWSWIRE) — Wintrust Financial Corporation (Nasdaq: WTFC) today announced Amy Yuhn has been named […]Read More
0 NASDAQ Companies - March 27, 2025Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™Seventh GPO Agreement Signed Since EluPro’s Launch SILVER SPRING, Md., March 27, 2025 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) […]Read More
0 NASDAQ Companies - March 27, 2025Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in AcromegalySAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the European Medicines Agency […]Read More
0 NASDAQ Companies - March 27, 2025Global Water Completes $32.2 Million Public Offering of Common Stock; Underwriters Exercise Full Over-Allotment OptionPHOENIX, March 27, 2025 (GLOBE NEWSWIRE) — Global Water Resources, Inc. (NASDAQ: GWRS), a pure- play water resource management company, […]Read More
0 NASDAQ Companies - March 27, 2025CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update– Phase 1 clinical trial of CMP-CPS-001 in Urea Cycle Disorders (UCDs) ongoing, with dosing completed in two of four […]Read More
0 NYSE Companies - March 27, 2025Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was Reports Fourth Quarter and Full-Year Fiscal 2024 ResultsATLANTA, March 27, 2025 (GLOBE NEWSWIRE) — Oxford Industries, Inc. (NYSE:OXM) today announced financial results for its fourth quarter and […]Read More
0 NYSE Companies - March 27, 2025Better Choice Company Announces Fourth Quarter and Full Year 2024 Financial ResultsFourth Quarter 2024 Revenue Growth of 26% Year-Over-Year to $7.2 million Fourth Quarter 2024 Loss per Share Improves 97% Year-Over-Year to […]Read More